Nobel Biocare sees weak dental market for rest of 2012
Austerity-hit Swiss dental implant maker Nobel Biocare Holding AG ditched its forecasts for global market growth in 2012, warning of a modest decline for the rest of the year as demand falls prey to poor economic conditions. The economic downturn has caused patients to put off pricey dental work, hurting implant makers like Nobel Biocare and rival Straumann Holding AG, which on Tuesday cut its outlook to "flat at best." Nobel Biocare, which had forecast the market for its screw-in prosthetic teeth — which can cost thousands of francs apiece — would grow in low single digits in 2012, said it had declined modestly in the first half of the year.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063